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a  b  s  t  r  a  c  t
Optical  nanoparticles  (NPs)  have  the  potential  to provide  new  tools  for diagnosis  and  treat-
ment of  human  diseases,  however,  their  nanotoxicity  and  biological  characteristics  are
still unclear.  Here,  we prepared  a series  of typical  NPs (including  gold  nanospheres,  gold
nanorods,  silver  nanopheres,  silver  triangular  nanoplates  and  quantum  dots)  with  differ-
ent material  and  surface  chemical  modiﬁcation  for nanotoxicity  test.  Cell  proliferation  was
investigated  by SRB  assay  where  the  NPs  were  co-cultured  with  cancer  cells.  It was  found
that NPs’  toxicity  was  highly  correlated  to different  factors—material  selection,  physical
size/surface  area,  shape,  and  surface  chemical  property,  etc.  This  work  has  the  potential  to
provide a uniform  and  systematic  information  when  they  are  applied  as  probes  in  biologicalold nanorods
ilver nanospheres
ilver  triangular nanoplates
dTe/CdS  quantum dots
ela  cells
epG2 cells
and medical  ﬁelds.
© 2014  Published  by  Elsevier  Ireland  Ltd.  This  is  an open  access  article  under  the  CC
BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).RB
. IntroductionWith rapidly growing interests in nano-research, the
oxicity of nanoparticles (NPs) is becoming an increasingly
∗ Corresponding author at: State Key Laboratory of Luminescence
nd Applications, Changchun Institute of Optics, Fine Mechanics and
hysics, Chinese Academy of Sciences, Dong Nanhu Road 3888, Changchun
30033, PR China. Tel.: +86 431 86708566; fax: +86 431 86708566.
∗∗ Corresponding author at: Department of Pharmacology, Norman
ethune College of Medicine, Jilin University, Changchun 130021, PR
hina. Tel.: +86 431 85619799; fax: +86 431 85619799.
 ∗ ∗ Corresponding author at: Interdisciplinary Nanoscience Center
iNANO), Aarhus University, DK-8000 Aarhus C, Denmark.
el.:  +45 50356224.
E-mail addresses: jlu jwy@163.com (W.  Ji), lijing@jlu.edu.cn (J. Li),
ong@inano.au.dk (J. Song).
1 These authors contributed equally to this work.
http://dx.doi.org/10.1016/j.toxrep.2014.05.009
214-7500/© 2014 Published by Elsevier Ireland Ltd. This is an open access articl
y-nc-nd/3.0/).important issue in nanotechnology [11]. However, little is
known  about the health risks and toxicity of these nano-
materials [11]. In addition, due to the increased production
and use of NPs in various ﬁelds, the side effect of NPs is
an  emerging and growing concern both academically and
socially  [11]. Recommendations for the use of NPs in vari-
ous  ﬁelds have emerged as a result of these initial toxicity
studies [11]. Several previous studies have investigated the
toxicity  of NPs based on various factors, such as shape, size,
surface  chemistry, chemical composition, surface activity
and  solubility [3,13,16,14]. For example, series of investi-
gations have been ﬁnished on the nanotoxicology of carbon
nanomaterials, ferric oxide NPs and TiO2 NPs [9,34,29].The biomedical applications of NPs, especially the NPs
with  optical properties, have been extensively studied in
the  past decade, especially in the term of drug and bio-
labeling, biosensors, cancer treatment and diagnostic tools
e under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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[18,11,35]. Due to the special physical–chemical proper-
ties,  the applications of NPs with optical properties in
biological ﬁelds are widely developed, e.g., metal plas-
monic NPs gold nanospheres (GNSs), gold nanorods (GNRs),
silver  nanospheres (SNSs), silver triangular nanoplates
(STNPs), etc., and semiconductor quantum dots (QDs)
(CdSe, CdTe, etc.). The nanotoxicology of these NPs is par-
ticularly  signiﬁcant due to the consideration of biological
safety. Prasad et al. [21] have evaluated the cytotoxic
and genotoxic assessment of glycolipid-reduced/-capped
gold and silver spherical NPs. They found that gold NPs
are  more cytocompatible than similar silver NPs, which
demonstrated that silver NPs could cause more DNA
damage compared to gold NPs. Chan et al. [8] have
found that the gold nanorods after the surface coating
with poly (diallyldimethylammonium chloride)-poly(4-
styrenesulfonic acid) system have negligible impact on
cell  function, while a very low number of genes experi-
ence any signiﬁcant change in expression via the effect of
surface  chemistry on gold nanorods uptake, toxicity, and
gene  expression in mammalian cells. Clift et al. [4] have
investigated that different surface-coated QDs will cause
oxidative stress and affect macrophage cell signaling in
vitro.  Ying et al. [24] have proved that the cellular inter-
action induced toxicity of the QDs is dose-dependent. At
the  same time, the cationic and hydrophobic QDs have
stronger interactions with cells than the anionic QDs. More
important, the cationic QDs are the most toxic, but their
toxicity could be reduced by introducing poly(ethylene
glycol) (PEG) on the QDs surface. Su et al. investigated
the cytotoxicity of aqueous-synthesized CdTe QDs and the
relative  contributions from released cadmium ions and
demonstrated that after the surface passivation with CdS
and  ZnSe shell, the cytotoxicity of the CdTe QDs will be
greatly  suppressed [22,23].
To date, the nanotoxicity studies are mainly focused on
single  variable quantity for the control experiments and at
the  same time all the results are investigated separately
[3,16,14]. Furthermore, the used NPs are often surface-
modiﬁed with substitution of the original surface group
from  the classical synthesis batch, where the experiments
are less applied and followed [21,8,24]. However, a more
rigorous evaluation of nanotoxicology in the same platform
is  needed in order to conﬁdently regulate the safe use of
all  forms of NPs with optical utilities. The nanotoxicology
investigation of all the popularly optical NPs in the same
platform or system has not been published till now.
In  this work, we prepared the biological-compatible
aqueous gold nanospheres, gold nanorods, silver
nanospheres, silver triangular nanoplates, CdTe/CdS
core/shell QDs and then investigated the nanotoxicity of
these  NPs in both of human hepatocarcinoma cell line
HepG2 and human cervical carcinoma Hela cells. Those
two  cell line have stronger endocytosis comparing with
other  cell lines and were commonly used to evaluate
cytotocixity of antitumor drugs with Sulforhodamine B
(SRB)  assay [12,27,20]. Nanoparticles’ toxicity is highly
correlated to different factors, including material selection,
physical size/surface area, appearance shape, and surface
chemical property. From our results, the nanotoxicity
of all the nanopartilces is dosage-dependent, but therts 1 (2014) 137–144
nanotoxicity of the same-material metal nanopartilces
with different shape is different (e.g., SNSs vs. STNPs, GNSs
vs.  GNRs); the nanotoxicity of the same-shape nanopar-
tilces with different material is different (e.g., SNSs vs.
GNSs  vs. QDs); the nanotoxicity of the same-material and
shape  metal nanopartilces with different surface group
is  different (e.g., citrate capped GNSs vs. CTAB capped
GNSs); the nanotoxicity of the same-material and shape
nanopartilces with different size is different (e.g., 3 nm
QDs  vs. 5 nm QDs, 15 nm GNSs vs. 30 nm GNSs), and the
nanotoxicity of the same nanopartilces to different cell
line  is different (e.g., Hela cells vs. HepG2 cells). This work
has  systematically investigated the nanotoxicity of these
optical  NPs and has the potential to provide a uniform and
systematic information or reference when these NPs are
applied  as probes in biological and medical ﬁelds.
2. Materials and methods
2.1.  Chemicals and reagents
Fetal  bovine serum (FBS), DMEM high glucose medium,
penicillin and streptomycin were obtained from Beyotime
Institute of Biotechnology (Haimen, China). Sulforho-
damine B (SRB), trichloroacetic acid (TCA), chloroauric acid
trihydrate  (HAuCl4·3H2O, ≥99.9%) and sodium borohy-
dride (NaBH4, ≥98%), were purchased from Sigma–Aldrich
(St. Louis, MO). Hexadecyltrimethylammonium bromide
(CTAB, ∼99%) and l-ascorbic acid (≥99.5%) were purchased
from Sigma. Silver nitrate (AgNO3, ≥99%) was purchased
from Fluka. Deionized water was puriﬁed through a
Milli-Q  water puriﬁcation system and the resistivity was
18.2  M cm.
2.2. Synthesis and characterization of gold nanospheres
GNSs were prepared according to the standard sodium
citrate reduction method. Typically, 45 mL deionized water
and  5 mL  HAuCl4 (2.5 mM)  aqueous solutions were mixed
in  a three-neck ﬂask and heated to 100 ◦C. Subsequently,
1% sodium citrate solution was quickly added into the ﬂask.
The  color of the solution rapidly changed from tint yellow
to  black and red or deep purple. After 1 h, the GNSs were
cooled to room temperature waiting for the next nanotox-
icity  measurement. The size could be tuned by changing
the volume of the additional sodium citrate. As shown in
the  ﬁeld-emission scanning electron microscope (FESEM)
of  Fig. 1A and B, the size of as-prepared GNSs was about
15  nm and 30 nm,  respectively. The plasmon absorption
peaks were localized at 520 nm and 525 nm (shown in
Fig.  2A).
2.3. Synthesis and characterization of gold nanorods
The synthesis of gold nanorods was  a traditionally seed-
mediated growth procedure [15,17,32], in which Au salt
was  reduced initially with a strong reducing agent, in
water  at room temperature. Simply, the Au seed parti-
cles  were prepared by reduction of HAuCl4 (0.25 mM)  in
CTAB  solution with the reduced reagent-ice-cold sodium
borohydride. Subsequent reduction of more metal salt
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eig. 1. FESEM results of 15 (A) and 30 nm (B) GNSs, 15 nm × 44 nm GNRs (
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ith a weak reducing agent, in the presence of structure-
irecting additives, leads to the controlled formation
f gold nanorods. Brieﬂy, a 25 mL  growth solution was
repared by reduction of 0.5 mM HAuCl4 in a solution con-
aining  CTAB, 0.05 mM silver nitrate and 176 L of ascorbic
cid.  The color of the solution rapidly changed from golden
o  colorless after the introduction of ascorbic acid. 36 L of
he  seed solution was then added into the growth solution
nd  the color of the solution slowly changed from color-
ess  to deep purple. Ultimately, the bilayer CTAB-coated
old nanorods were obtained after several hours’ stirring.
s  shown in the FESEM of Fig. 1C, the size of the prepared
anorods was mainly 15 nm in width and 44 nm in length
ith  plasmon absorption peaks at 517 (transverse plasmon
ig. 2. The plasmon absorption spectra of 15 and 30 nm GNSs (A), 15 nm × 44 n
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band)  and 714 nm (longitudinal plasmon band) (shown in
Fig.  2B).
2.4. Synthesis and characterization of silver nanospheres
SNSs were prepared according to the standard sodium
citrate reduction method. Typically, 25 mL  deionized water
and  0.25 mL  AgNO3 (10 mM)  aqueous solutions were mixed
in  a conical ﬂask at room temperature. Subsequently, 1%
sodium  citrate solution was quickly added into the ﬂask.
The  color of the solution rapidly changed from colorless to
pale  yellow. After 1 h, the SNSs were prepared and waited
for  the next nanotoxicity measurement. As shown in the
FESEM  of Fig. 1D, the size of as-prepared SNSs was about
m GNRs (B), 30 nm SNSs (C), 60 nm STNPs (D) and the absorption and
gy Repo
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30 nm.  The plasmon absorption peaks were localized at
411  nm (shown in Fig. 2C).
2.5. Synthesis and characterization of silver triangular
nanoplates
A typical experiment was carried out by the photocon-
version method [33,25]. First, silver seeds were prepared
by  dropwise addition of NaBH4 solution (8 mM,  1 mL)  to
an  aqueous solution of AgNO3 (0.1 mM,  99 mL)  in the pres-
ence  of trisodium citrate (1 mM)  under vigorous stirring.
Next, the yellow silver seeds (100 mL,  in glass conical ﬂask
with  a cover) were exposed under a sodium lamp (NAV-T
70  model from Osram China Lighting Co., Ltd.). The irradi-
ation  power density of the sodium lamp was determined
to be 80.6 mW/cm2 as measured using a Gentec-EO Solo
2  energy and power meter at the position of silver solu-
tion.  The color of silver colloids changed from yellow to
green  and blue during the irradiation process. After 2 h, the
STNPs  were prepared and waited for the next nanotoxic-
ity measurement. As shown in the FESEM of Fig. 1E, the
size  of as-prepared STNPs was about 60 nm.  The in-plate
dipole plasmon resonance absorption peaks are localized
at  636 nm (shown in Fig. 2D).
2.6. Synthesis and characterization of CdTe/CdS
core/shell QDs
The  3-mercaptopropionic acid stabilized CdTe/CdS
core/shell QDs were prepared according to our previous
work [31]. The green and red CdTe/CdS core/shell QDs were
emitted  at 527 and 611 nm (Fig. 2E) with sizes of about
2.5  nm and 5 nm (shown in Fig. 1F and G). The absorption
spectra showed that there is a gradually enhanced absorp-
tion  below the band gap, which property is different from
that  of the metal NPs due to the native absorption energy
level of the semiconductor QDs.
2.7. Cell culture and SRB assay
Human hepatocellular carcinoma HepG2 cells and
Human cervical cancer Hela cells were maintained in
DMEM  high glucose medium supplemented with 10% FBS,
100  units/ml penicillin, and 100 g/ml streptomycin in an
atmosphere of 95% air and 5% CO2 at 37 ◦C. The SRB assay is
routinely used for cytotoxicity determination, based on the
measurement of live cell protein content. It was performed
in  96-well plates in octuplicate after 48 h treatment. In
brief,  cells were seeded at a density of 5 × 103 cells/well
overnight, and treated with the indicated concentrations of
NPs  for 48 h. Afterwards, 100 L of 20% TCA was added to
the  culture medium in each well and refrigerated at 4 ◦C for
3  h, then the supernatant was discarded and the plate was
washed  for 5 times with water and air dried. 100 L of SRB
solution 0.4% (w/v) in 1% acetic acid was added to each well
and  incubated for 30 min  at room temperature. Unbounded
SRB  was ﬂicked off the plates and air dried the plates. Bound
SRB  was solubilized with 150 L of 10 mM Tris–HCl to each
well  and the plate was shaked for 5 min. The optical density
(OD)  at 570 nm wavelength was measured and the ratio
of  cell viability to control group was calculated from therts 1 (2014) 137–144
SRB  data. The concern that various nanaoparticles, such as
GNSs,  GNRs and QDs in 570 nm would interfere with the
SRB  determination was  resolved by rinsing off the excess
NPs  which resided outside the cell or adhered to the dead
cells  in SRB assay procedure [28]. The control group also
went  through the same process for SRB assay.
3. Results
3.1. Effect of gold nanoparticles on cell viability of HepG2
and  Hela cells
As  shown in the FESEM of Fig. 1A and B, the size of
as-prepared GNSs was about 15 nm and 30 nm,  respec-
tively. The plasmon absorption peaks were localized at
520  nm and 525 nm (shown in Fig. 2A), the red-shift of
the  absorption peaks reﬂected the size effect of gold NPs
clearly. As shown in the FESEM of Fig. 1C, the size of the
prepared nanorods was  mainly 15 nm in width and 44 nm
in  length with plasmon absorption peaks at 517 (trans-
verse plasmon band) and 714 nm (longitudinal plasmon
band) (shown in Fig. 2B). As shown in Fig. 3A, the cell
viability of 15 nm and 30 nm citrate sodium capped gold
nanospheres in HepG2 cells was assessed after 48 h treat-
ment  with a series of concentrations of the NPs from 0 to
200  pM.  It was shown that 15 nm GNSs did not inﬂuence
cell growth even in the 200 pM concentration, however,
30 nm GNSs showed the reduction of HepG2 cells prolifer-
ation  ratio by 15.7% in 50 pM,  21.9% in 100 pM and 28.9%
in  200 pM compared with control group. The 15 nm and
30  nm GNSs on cell growth in Hela cells showed almost
the  same effect as HepG2 cells (data not shown). The
results indicated that the toxicity of GNSs was  increased
by  the size-dependent manner (Fig. 3A). Moreover, the
inﬂuences of CTAB-capped gold nanorods on cell viability
were  measured in HepG2 and Hela cells with the same cul-
tural  conditions. It showed that a signiﬁcant damage was
exhibited both in cell proliferation and cell morphology.
As shown in Fig. 3B, 0.625 pM of GNRs induced 15.8% and
22.1%  reduction of cell survival rate in HepG2 and Hela cells
respectively. The median inhibition concentration (IC50) of
GNRs  in HepG2 cells is only 1.75 pM,  which is signiﬁcant
less than that of 30 nm GNSs (more than 200 pM). Shrinked
cell  membrane and cell debris were observed in HepG2
cells treated with 12.5 pM CTAB capped GNSs and GNRs for
48  h (Fig. 3D), which cellular morphology was  greatly dif-
ferent  from the control sample or the citrate capped GNSs.
To  elucidate the cause of signiﬁcant difference in cytotox-
icity  between GNSs and GNRs, the impact of 45 nm CTAB
capped GNSs was  detected in HepG2 cells. The result was
shown  in Fig. 3C, 45 nm GNSs with the same surface group
inhibited cell proliferation with the same trend to GNRs,
which  showed the obviously higher nanotoxicity than cit-
rate  capped GNSs, indicated that it was the surface ligand,
not  the shape played a key role on cell survival in thisthe  CTAB capped GNSs (45 nm)  showed higher nanotoxic-
ity  compared to the GNRs (15 nm × 44 nm), which was  due
to  the larger surface area of the GNSs contacted with the
HepG2  cells.
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Fig. 3. Effect of gold NPs on cell viability and cell morphology in HepG2 and Hela cells. (A) 15 and 30 nm GNSs on cell viability in HepG2 cells. (B) GNRs on
cell  viability in HepG2 and Hela cells. (C) Comparison of 30 nm GNSs, CTAB-GNSs (45 nm) and CTAB-GNRs (15 nm × 44 nm)  on cell viability in HepG2 cells.
(D)  HepG2 cell morphology in control (a), 30 nm GNSs (b), 45 nm CTAB-GNSs (c) and 15 nm × 44 nm CTAB-GNRs (d) after 48 h-treatment with the same



























s*p  < 0.01 vs. control group.
.2. Effect of silver nanoparticles on cell viability of Hela
ells  and HepG2 cells
As  shown in the FESEM of Fig. 1D, the size of as-prepared
NSs was about 30 nm.  The plasmon absorption peaks were
ocalized  at 411 nm (shown in Fig. 2C). As shown in the
ESEM of Fig. 1E, the size of as-prepared STNPs was about
0  nm.  The in-plate dipole plasmon resonance absorption
eaks are localized at 636 nm (shown in Fig. 2D). As shown
n  Fig. 4A, silver nanospheres (30 nm)  and silver triangular
anoplates (60 nm)  did not inﬂuence HepG2 cell growth
hen  the concentration was less than 200 g/ml. About
4%  decrease in cell viability was shown when the con-
entration reaches 400 g/ml. The cell growth curve was
lmost  overlapping between SNSs and STNPs, indicating
hat HepG2 cell has the same response with the differ-
nt shape of silver nanopaticles. Interestingly, for Hela cell
ines,  the cell growth curve of STNPs and SNSs began to
ifurcate at the point of the concentration of 50 g/ml,
nd STNPs showed increasing inhibitory percent of 11.8%,
5.6%  and 31.9% more than SNSs in 100, 200 and 400 g/ml,
uggesting that Hela cells were more susceptible to STNPs
omparing with the SNSs. In general, Hela cells was more
ensitive to silver NPs than HepG2 cells in cell viability as
ell  as cell morphology changed (shown in Fig. 4B), which
as  similar with the nanotoxicity of GNRs. The ﬁnding
ndicated the toxicity of silver NPs was of cell and shape
peciﬁc.3.3.  Effect of CdTe/CdS core/shell QDs on cell proliferation
of HepG2 cells Characterization
The  green and red CdTe/CdS core/shell QDs were emit-
ted  at 527 and 611 nm (Fig. 2E) with sizes of about 2.5 nm
and  5 nm (shown in Fig. 1F and G), the red-shift of the
absorption and emission peaks reﬂected the quantum size
effect  of QDs clearly. The effect of CdTe/CdS core/shell QDs
with  different size (2.5 nm green QDs and 5 nm red QDs) on
cell  proliferation was  detected in the concentration from
0.02  to 2 M.  The result showed that the cell growth was
gradually inhibited with the increase of QDs concentration.
5 nm QDs was  more toxic than 2.5 nm QDs at the same
concentration level, indicating the size was  the important
factor for QDs in cytotoxicity. The results were shown in
Fig.  5.
4.  Discussion
Cellular endocytosis, cellular delivery, and subcellular
targeting inducing nanotoxicity of a nanoparticle can be
inﬂuenced in several ways [24]. First, a nanoparticle has a
high  surface to-volume ratio, and thus any small change in
the  particle size, shape and/or surface functional group may
lead  to signiﬁcant alteration in cellular interaction. Conse-
quently, the cellular uptake, cytotoxicity, and subcellular
localization of NPs are highly sensitive to the particle size,
shape,  surface charge, hydrophobicity, and nature of the
142 Q. Zeng et al. / Toxicology Reports 1 (2014) 137–144
 and He
NPs (c) a
rbitrarilFig. 4. Effect of silver NPs on cell viability and cell morphology in HepG2
HepG2  cell morphology in control (a), 200 g/ml SNSs (b), 200 g/ml ST
STNPs  (f) after 48 h-treatment. The cell viability of control cells were set a
**p  < 0.01 vs. control group.
surface ligands. Second, a larger particle size and a higher
surface charge would often induce high nonspeciﬁc cellu-
lar  uptake of NPs, which further complicated the uptake
activity of afﬁnity ligands by reducing the speciﬁcity of
NPs.  Third, NPs often end up at lysosomes and prevent
subcellular targeting. As a result, based on the same mate-
rial,  shape, and surface group, the larger size GNSs (or QDs)
were  more toxic than smaller size GNSs (or QDs) at same
dosage administration concentration. It is reported that
the  surface charge plays a signiﬁcant role in the process
of  cellular uptake [1,8]. This means that a larger particle
size and a higher surface charge would often induce high
nonspeciﬁc cellular uptake of NPs [24]. As a result, the
larger  size and a higher surface charge NPs will cause a
relative  obvious interaction with the cell line and lead to a
serious  cell toxicity. Considering the same material, differ-
ent  shape would cause differently toxic results, e.g., STNPsla cells. (A) SNSs and STNPs on cell viability in HepG2 and Hela cells. (B)
nd Hela cells morphology in control (d), 200 g/ml SNSs (e), 200 g/ml
y to 100%. The data plotted are mean ± standard error (SE), n = 8. *p < 0.05,
were  more toxic than SNSs. Comparing with the inﬂuence
of  shape of the NPs, surface ligand functioned more crucial
effect  on the nanotoxicity of cells, e.g., CTAB capped GNSs
and  GNRs were obviously more toxic than citrate sodium
capped GNSs because CTAB, as well-known cationic sur-
factant,  could increase cell membrane permeability and
conjugate with nuclear acid [19]. On the other hand, the
CTAB  can damage mitochondria, and then induce apoptosis
[19].
A  growing body of evidences indicated that the mech-
anism of NPs on cytotoxicity is mostly related with the
induction of apoptosis in living system. However, the ini-
tiators  and signaling pathways of apoptosis are different,
which is depending on the special natures of NPs. Gao
et  al. [6] reported gold NPs caused hydrogen oxygen accu-
mulation by cytosolic glutathione (GSH) depletion and
subsequently activated mitochondrial apoptosis pathway.
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Fig. 5. Effect of 2.5 nm and 5 nm CdTe/CdS core/shell QDs on cell viability and cell morphology in HepG2 cells. (A) 2.5 nm and 5 nm CdTe/CdS core/shell
Q rol (a), 


























hDs  on cell viability in HepG2 cells. (B) HepG2 cells morphology in cont
f  0.1 M. The cell proliferation of control cells were set arbitrarily to 10
ontrol  group.
ang et al. [10] stated that gold NPs localizing in cell nuclei
ould  induce DNA damage and cytokinesis arrest. More-
ver,  the toxicity of silver NPs and QDs were depended on
he  dissolved ion concentration (such as silver ion, cad-
ium  ion, etc.) and surface coating [26,2]. Furthermore, the
roduction  of intracellular reactive oxygen species (ROS),
ncreased expression of cleaved caspase proteins and p53
ctivation were commonly involved in the mechanisms of
poptosis  induced by NPs [5,7,30]. In the present study,
ela  cell is more sensitive to STNPs than SNSs and HepG2
ell  is more susceptible to GNRs than GNSs, indicating that
here  is cell selective response to the shape of NPs.
The traditional gold NPs have been widely applied in
he  biological and medical ﬁelds for a long time since they
re  considered as owning better biocompatibility, on the
ontrary,  the CdSe and CdTe QDs are always controversial
n toxicological issues because of the heavy metal prop-
rty  of cadimium although Su et al. have demonstrated
hat after the surface passivation with CdS and ZnSe shell,
he  cytotoxicity of the CdTe QDs will be greatly suppressed
22,23]. Surprisingly, we  found that when the nanotoxic-
ty  of GNSs (30 nm)  and QDs (5 nm)  is on the same level
∼70%  cell viability), the dosage administration concentra-
ions of GNSs and QDs are 0.2 nM and 20 nM,  respectively.
his indicates that the nanotoxicity of GNSs is 100 times
igher than QDs. Since it is reported that the toxicity of theGQDs (b) and RQDs (c) for 48 h-treatment with the same concentration
data plotted are mean ± standard error (SE), n = 8. *p < 0.05, **p < 0.01 vs.
silver  NPs are more serious than the gold NPs since silver
NPs  cause more DNA damage compared to gold NPs [21].
Furthermore, we have proved that the CTAB capped GNRs
are  more toxic than the GNSs. We  can draw a conclusion
that size and surface properties but not the elemental com-
position  of the NPs themselves are more signiﬁcant on the
cellular  nanotoxicity, which may  provide a novel judgment
on  the nanotoxicity of aqueous cadmium-containing QDs.
In  conclusion, we  have prepared the biological-
compatible aqueous gold nanospheres, gold nanorods,
silver nanospheres, silver triangular nanoplates, CdTe/CdS
core/shell QDs according to the traditional method, and
then  we  investigated the nanotoxicity of these NPs in
human  hepatocarcinoma cell line HepG2 and human cervi-
cal  carcinoma Hela cells. NPs’ toxicity is highly correlated to
many  characteristics, including material selection, physical
size/surface area, appearance shape, and surface chem-
ical  property. We  observed that the nanotoxicity of all
the  NPs is dosage-dependent, but the nanotoxicity of the
same-material metal NPs with different shape is differ-
ent  (e.g., SNSs vs. STNPs, GNSs vs. GNRs), the nanotoxicity
of the same-shape NPs with different material is differ-
ent  (e.g., SNSs vs. GNSs vs. QDs), the nanotoxicity of the
same-material and shape metal NPs with different surface
group  is different (e.g., citrate capped GNSs vs. CTAB capped
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NPs with different size is different (e.g., 3 nm QDs vs. 5 nm
QDs,  15 nm GNSs vs. 30 nm GNSs), and the nanotoxicity of
the  same NPs to different cell line is different (e.g., Hela
cells  vs. HepG2 cells). Based on the ﬁndings, it seems that
not  only the dose is a key parameter that affects toxicity of
NPs,  but also other properties such as particle size, rough-
ness,  shape and charge are the important factors impacting
cytotoxicity. This work has systematically investigated the
nanotoxicity of NPs owning powerful optical properties,
and has the potential to provide a uniform and system-
atic information estimation or reference when these NPs
are  applied as probes in biological and medical ﬁelds.
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